Australia markets closed

Acasti Pharma Inc. (ACST)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.9285-0.0115 (-0.39%)
At close: 04:00PM EDT
3.0300 +0.10 (+3.47%)
After hours: 06:17PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
0
0
0
196
Cost of revenue
-
-
0
76
Gross profit
-
-
0
120
Operating expenses
Research development
4,638
9,972
5,559
4,173
Selling general and administrative
7,617
8,212
9,781
6,655
Total operating expenses
12,269
18,247
15,340
10,836
Operating income or loss
-12,269
-18,247
-15,340
-10,716
Interest expense
-
-
-
0
Total other income/expenses net
-37,093
-33,970
4,796
-8,805
Income before tax
-48,588
-51,971
-10,467
-19,678
Income tax expense
-9,814
-9,542
-648
0
Income from continuing operations
-38,774
-42,429
-9,819
-19,678
Net income
-38,774
-42,429
-9,819
-19,678
Net income available to common shareholders
-38,774
-42,429
-9,819
-19,678
Basic EPS
-5.65
-5.70
-1.62
-7.98
Diluted EPS
-5.65
-5.70
-1.62
-7.98
Basic average shares
7,699
7,435
6,140
2,471
Diluted average shares
7,699
7,435
6,140
2,471